OverviewChartNewsTraderScreen

UniCredit Discount Zert 22UA 27.0.../  DE000HD1NMD7  /

EUWAX
7/9/2024  3:39:23 PM Chg.+0.03 Bid3:48:23 PM Ask3:48:23 PM Underlying Strike price Expiration date Option type
69.61EUR +0.04% 69.57
Bid Size: 500		 69.60
Ask Size: 500		 BIONTECH SE SPON. AD... - - 9/27/2024 Call
GlobeNewswire 6/27 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire 6/24 BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire 6/1 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire 5/29 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 5/21 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 5/17 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
TeleTrader 5/6 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 5/6 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 4/22 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 4/7 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
TeleTrader 3/20 BioNTech Q4 revenue plunges 65% to €1.48B
GlobeNewswire 3/20 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 3/20 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 3/11 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 3/7 BioNTech Announces Planned Retirement of Sean Marett
GlobeNewswire 3/6 BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update ...
GlobeNewswire 2/8 BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire 1/31 BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjuga...
GlobeNewswire 1/22 BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/...
TeleTrader 1/9 BioNTech sees $3.3B revenue for 2024, expanding into oncology
GlobeNewswire 1/9 BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 12/21/2023 BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Can...
GlobeNewswire 12/18/2023 BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
GlobeNewswire 12/12/2023 BioNTech to Inaugurate First African Site on December 18, 2023
TeleTrader 11/6/2023 BioNTech Q3 revenue plummets 74% to €895M